FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the chemical-pharmaceutical industry and represents a method for drug preparation encapsulation by non-solvent addition differing by the fact that fenbendazole is used as a microcapsule nucleus, whereas a microcapsule coating is sodium carboxymethyl cellulose; herewith fenbendazole 100 mg is dissolved in dimethylsulphoxide, or dioxane, dimethylformamide 1 ml; the prepared mixture is dispersed in a sodium carboxymethyl cellulose solution in isopropanole containing the above polymer 300 mg in the presence of E472c surfactant 0.01 g, and stirred at 1000 rps, added with butanol 2 ml and distilled water 1 ml; the prepared suspension of microcapsules is filtered and dried at 25°C.
EFFECT: invention provides facilitating and accelerating the microencapsulation process, as well as lowered accompanying loss (higher weight yield).
3 ex
Title | Year | Author | Number |
---|---|---|---|
FENBENDAZOLE ENCAPSULATION METHOD | 2013 |
|
RU2548715C1 |
METHOD OF FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2532409C1 |
METHOD OF FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2545716C2 |
FENBENDAZOLE ENCAPSULATION METHOD | 2013 |
|
RU2547557C2 |
METHOD OF FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2544167C2 |
METHOD OF FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2537258C1 |
FENBENDAZOLE ENCAPSULATION METHOD | 2014 |
|
RU2552344C1 |
METHOD FOR FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2537255C1 |
METHOD OF FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2533454C1 |
METHOD FOR FENBENDAZOLE ENCAPSULATION | 2013 |
|
RU2538670C2 |
Authors
Dates
2015-04-20—Published
2013-07-10—Filed